TNF and rheumatoid arthritis: A recent retrospective study analyzed the influence of TNF-α inhibitors (TNFi) and an anti-IL-6 receptor antibody tocilizumab (TCZ) on glucose metabolism in 221 patients with rheumatoid arthritis, including 109 patients with T2D [66].